DI MAURO, VITTORIA
 Distribuzione geografica
Continente #
NA - Nord America 156
AS - Asia 106
EU - Europa 77
SA - Sud America 7
Totale 346
Nazione #
US - Stati Uniti d'America 154
HK - Hong Kong 44
DE - Germania 18
IT - Italia 18
SG - Singapore 18
SE - Svezia 13
CN - Cina 12
RU - Federazione Russa 11
TR - Turchia 11
ID - Indonesia 10
IE - Irlanda 9
BR - Brasile 7
VN - Vietnam 4
GB - Regno Unito 3
JP - Giappone 3
CA - Canada 2
IQ - Iraq 2
CZ - Repubblica Ceca 1
FR - Francia 1
NL - Olanda 1
PH - Filippine 1
PL - Polonia 1
UA - Ucraina 1
UZ - Uzbekistan 1
Totale 346
Città #
Ann Arbor 61
Hong Kong 39
Singapore 15
Jakarta 10
Dublin 9
Istanbul 9
Fairfield 8
Frankfurt am Main 7
Princeton 6
Ashburn 5
Houston 5
Seattle 5
Wilmington 5
Beijing 4
Cagliari 4
Chandler 4
New York 4
Santa Clara 4
Altamura 3
Buena Park 3
Cambridge 3
Dearborn 3
Milan 3
Nanjing 3
Tokyo 3
Woodbridge 3
Capão da Canoa 2
Council Bluffs 2
Erbil 2
Goiânia 2
Jacksonville 2
Kocaeli 2
Lawrence 2
Norwalk 2
Toronto 2
Andover 1
Baoding 1
Benxi 1
Bonndorf 1
Brentford 1
Chengdu 1
Esslingen am Neckar 1
Gravataí 1
Groningen 1
Guangzhou 1
Guaratinguetá 1
Hounslow 1
Los Angeles 1
Lucca 1
Monrovia 1
New Haven 1
Nuremberg 1
Porto Alegre 1
Rzeszów 1
San Diego 1
Tashkent 1
Totale 267
Nome #
Peptide-Based Targeting of the L-Type Calcium Channel Corrects the Loss-of-Function Phenotype of Two Novel Mutations of the CACNA1 Gene Associated With Brugada Syndrome 134
Novel insights into the protective role of miR-133a in the heart and its therapeutic application for the treatment of cardiac pathologies 120
Novel basic science insights to improve the management of heart failure: Review of the working group on cellular and molecular biology of the heart of the italian society of cardiology 72
Diagnostic and Therapeutic Aptamers: A Promising Pathway to Improved Cardiovascular Disease Management 15
Modulation of LTCC Pathways by a Melusin Mimetic Increases Ventricular Contractility During LPS-Induced Cardiomyopathy 7
Nano-miR-133a Replacement Therapy Blunts Pressure Overload–Induced Heart Failure 7
The emerging role of epigenetics in therapeutic targeting of cardiomyopathies 6
Lung-to-Heart Nano-in-Micro Peptide Promotes Cardiac Recovery in a Pig Model of Chronic Heart Failure 6
Therapeutic Potential of EVs: Targeting Cardiovascular Diseases 6
SNAI1 is upregulated during muscle regeneration and represses FGF21 and ATF3 expression by directly binding their promoters 6
Totale 379
Categoria #
all - tutte 1.522
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.522


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203 0 0 0 0 0 0 0 0 0 0 3 0
2020/202175 0 1 1 1 0 1 16 8 15 15 7 10
2021/202250 5 8 6 3 2 3 1 3 3 0 4 12
2022/202358 18 10 4 2 1 11 1 2 5 0 2 2
2023/202452 2 0 0 2 11 15 4 5 7 0 0 6
2024/2025124 7 17 2 6 9 19 52 12 0 0 0 0
Totale 379